Higher apoptotic state in Fabry disease peripheral blood mononuclear cells.. Effect of globotriaosylceramide

Molecular Genetics and Metabolism

Volumn 104, Issue 3, 2011, Pages 319-324

  De Francesco, Pablo N ^a   Mucci, Juan M ^a   Ceci, Romina ^a   Fossati, Carlos A ^a   Rozenfeld, Paula A ^a  

^a FACULTAD DE CIENCIAS EXACTAS   (Argentina)

Author keywords

Apoptosis; Enzyme replacement treatment; Fabry disease; Globotriaosylceramide; Pathogenesis

Indexed keywords

CASPASE; GLOBOTRIAOSYLCERAMIDE;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CELL DEATH; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); ENDOPLASMIC RETICULUM STRESS; ENZYME REPLACEMENT; FABRY DISEASE; FEMALE; HUMAN; HUMAN CELL; MALE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN FOLDING; SCHOOL CHILD;

ADOLESCENT; ADULT; ALPHA-GALACTOSIDASE; ANALYSIS OF VARIANCE; ANNEXIN A5; APOPTOSIS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME REPLACEMENT THERAPY; FABRY DISEASE; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; IN SITU NICK-END LABELING; ISOENZYMES; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TRIHEXOSYLCERAMIDES;

EID: 82455162407     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.06.007     Document Type: Article

References (28)

1. Brady R.O., Gal A.E., Bradley R.M., Martensson E., Warshaw A.L., Laster L. Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. N. Engl. J. Med. 1967, 276:1163-1167.
2. Kint J.A. Fabry's disease: alpha-galactosidase deficiency. Science 1970, 167:1268-1269.
3. Desnick R.J., Ioannou Y.A., Eng C.M. α-galactosidase A deficiency: Fabry disease. The Metabolic and Molecular Bases of Inherited Disease 2000, 3733-3774. McGraw-Hill Professional, New York. 8th ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
4. Ballabio A., Gieselmann V. Lysosomal disorders: from storage to cellular damage. Biochim. Biophys. Acta. 2009, 1793:684-696.
5. Rozenfeld P., Agriello E., De Francesco N., Martinez P., Fossati C. Leukocyte perturbation associated with Fabry disease. J. Inherit. Metab. Dis. 2009, 10.1007/s10545-009-1060-9.
6. DeGraba T., Azhar S., Dignat-George F., Brown E., Boutière B., Altarescu G., et al. Profile of endothelial and leukocyte activation in Fabry patients. Ann. Neurol. 2000, 47:229-233.
7. Shen J.-S., Meng X.-L., Moore D.F., Quirk J.M., Shayman J.A., Schiffmann R., et al. Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells. Mol. Genet. Metab. 2008, 95:163-168.
8. Simonaro C.M., Haskins M.E., Schuchman E.H. Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses. Lab. Invest. 2001, 81:1319-1328.
9. Hong Y.B., Kim E.Y., Jung S.-C. Down-regulation of Bcl-2 in the fetal brain of the Gaucher disease mouse model: a possible role in the neuronal loss. J. Hum. Genet. 2004, 49:349-354.
10. Wu Y.-P., Mizukami H., Matsuda J., Saito Y., Proia R.L., Suzuki K. Apoptosis accompanied by up-regulation of TNF-alpha death pathway genes in the brain of Niemann-Pick type C disease. Mol. Genet. Metab. 2005, 84:9-17.
11. Wei H., Kim S.-J., Zhang Z., Tsai P.-C., Wisniewski K.E., Mukherjee A.B. ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones. Hum. Mol. Genet. 2008, 17:469-477.
12. Green D.R., Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004, 305:626-629.
13. Nagata S. Apoptosis by death factor. Cell 1997, 88:355-365.
14. Boyce M., Yuan J. Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ. 2006, 13:363-373.
15. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science 1998, 281:1312-1316.
16. Marshall O.J. PerlPrimer: cross-platform, graphical primer design for standard, bisulphite and real-time PCR. Bioinformatics 2004, 20:2471-2472.
17. Moore D.F., Goldin E., Gelderman M.P., Robinson C., Baer J., Ries M., et al. Apoptotic abnormalities in differential gene expression in peripheral blood mononuclear cells from children with Fabry disease. Acta Paediatr. Suppl. 2008, 97:48-52.
18. Zhang Z., Lee Y.-C., Kim S.-J., Choi M.S., Tsai P.-C., Xu Y., et al. Palmitoyl-protein thioesterase-1 deficiency mediates the activation of the unfolded protein response and neuronal apoptosis in INCL. Hum. Mol. Genet. 2006, 15:337-346.
19. Hamano K., Hayashi M., Shioda K., Fukatsu R., Mizutani S. Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue. Acta Neuropathol. 2008, 115:547-559.
20. Li H., Repa J.J., Valasek M.A., Beltroy E.P., Turley S.D., German D.C., et al. Molecular, anatomical, and biochemical events associated with neurodegeneration in mice with Niemann-Pick type C disease. J. Neuropathol. Exp. Neurol. 2005, 64:323-333.
21. Huang J.Q., Trasler J.M., Igdoura S., Michaud J., Hanal N., Gravel R.A. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases. Hum. Mol. Genet. 1997, 6:1879-1885.
22. Oya Y., Proia R.L., Norflus F., Tifft C.J., Langaman C., Suzuki K. Distribution of enzyme-bearing cells in GM2 gangliosidosis mice: regionally specific pattern of cellular infiltration following bone marrow transplantation. Acta Neuropathol. 2000, 99:161-168.
23. Jeyakumar M., Thomas R., Elliot-Smith E., Smith D.A., van der Spoel A.C., d'Azzo A., et al. Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain 2003, 126:974-987.
24. Momoi T. Caspases involved in ER stress-mediated cell death. J. Chem. Neuroanat. 2004, 28:101-105.
25. Farfel-Becker T., Vitner E., Dekel H., Leshem N., Enquist I.B., Karlsson S., et al. No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease. Hum. Mol. Genet. 2009, 18:1482-1488.
26. Macho A., Hirsch T., Marzo I., Marchetti P., Dallaporta B., Susin S.A., et al. Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis. J. Immunol. 1997, 158:4612-4619.
27. Kroemer G., Dallaporta B., Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 1998, 60:619-642.
28. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999, 397:441-446.